Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model

Vaccine

Volumn 31, Issue 6, 2013, Pages 927-942

  Pitman, R J ^a   Nagy, L D ^a   Sculpher, M J ^a,b  

^a ICON PLC   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cost effectiveness; England; Epidemiology; Influenza; Mathematical model; Paediatric; Seasonal; Transmission model; Vaccination; Wales

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE;

ACUTE OTITIS MEDIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG COST; ECONOMIC EVALUATION; FEMALE; HEALTH CARE POLICY; HEALTH INSURANCE; HERD IMMUNITY; HUMAN; INFANT; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PEDIATRICS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; SINUSITIS; UNITED KINGDOM; VIRUS IMMUNITY; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; VACCINATION; WALES; YOUNG ADULT;

EID: 84872612562     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.010     Document Type: Article

References (59)

1. Pitman R.J., Melegaro A., Gelb D., Siddiqui M.R., Gay N.J., Edmunds W.J. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 2007, 54(June (6)):530-538. Available from: http://dx.doi.org/10.1016/j.jinf.2006.09.017.
2. Fleming D.M., Elliot A.J. Health benefits, risks, and cost-effectiveness of influenza vaccination in children. Pediatr Infect Dis J 2008, 27(November (11 Suppl.)):S154-S158. Available from: http://dx.doi.org/10.1097/INF.0b013e318183a5443.
3. Cohen G.M., Nettleman M.D. Economic impact of influenza vaccination in preschool children. Pediatrics 2000, 106(November (5)):973-976.
4. Luce B.R., Nichol K.L., Belshe R.B., Frick K.D., Li S.X., Boscoe A., et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 2008, 26(June (23)):2841-2848. Available from: http://dx.doi.org/10.1016/j.vaccine.2008.03.046.
5. Savidan E., Chevat C., Marsh G. Economic evidence of influenza vaccination in children. Health Policy 2008, 86(May (2-3)):142-152. Available from: http://dx.doi.org/10.1016/j.healthpol.2007.09.009.
6. Pitman R., White L., Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine 2012, 30:1208-1224.
7. Curtis L. Unit costs of health and social care 2008, Personal Social Services Research Unit, University of Kent.
8. General Practice Research Database. Available from: http://www.gprd.com/home/default.asp.
9. Bentley T.E., Price C., Brown P.J.B. Structural and lexical features of successive versions of the Read Codes. The proceedings of the 1996 annual conference of the Primary Health Care Specialist Group of the British Computer Society 1996, NHS Centre for Coding & Classification, Woodgate, Loughborough, Leicestershire LE11 2TG, Available from: http://www.phcsg.org/main/pastconf/camb96/readcode.htm (retrieved 2010.05.06).
10. Hospital Episode Statistics. Available from: http://www.hesonline.nhs.uk/.
11. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7(35):iii-iv. xi-xiii, 1-170.
12. BNF. British National Formulary, release 58, Joint Formulary Committee. Available from: http://bnf.org/bnf/bnf/current/index.htm.
13. NHS Costing and Cost Collection. Available from: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/NHScostingmanual/index.htm.
14. Begum F., Pebody R. Vaccination uptake among the 65 years and over and under 65 years at risk in England 2007-08. Influenza immunisation uptake monitoring programme 2008, Department of Health, Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1213083216553.
15. Pebody R.G., Begum F., Gates P., Noakes K., Salisbury D. Influenza vaccination coverage in England, 2000-2008. Euro Surveill 2008, 13(December (51)):1.
16. Jefferson T.O., Rivetti D., Pietrantonj C.D., Rivetti A., Demicheli V. Vaccines for preventing influenza in healthy adults 2007, Available from: http://dx.doi.org/10.1002/14651858.CD001269.pub3.
17. Jefferson T., Rivetti A., Harnden A., Pietrantonj C.D., Demicheli V. Vaccines for preventing influenza in healthy children 2008, Available from: http://dx.doi.org/10.1002/14651858.CD004879.pub3.
18. Negri E., Colombo C., Giordano L., Groth N., Apolone G., Vecchia C.L. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005, 23(April (22)):2851-2861. Available from: http://dx.doi.org/10.1016/j.vaccine.2004.11.053.
19. Zangwill K.M., Belshe R.B. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004, 23(March (3)):189-197.
20. Rhorer J., Ambrose C.S., Dickinson S., Hamilton H., Oleka N.A., Malinoski F.J., et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009, 27(February (7)):1101-1110. Available from: http://dx.doi.org/10.1016/j.vaccine.2008.11.093.
21. Ashkenazi S., Vertruyen A., Arístegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006, 25(October (10)):870-879.
22. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(February (7)):685-696.
23. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006, 25(October (10)):860-869. Available from: http://dx.doi.org/10.1097/01.inf.0000237797.14283.cf.
24. Pitman R., Fisman D., Zaric G.S., Postma M., Kretzschmar M., Edmunds J., et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making 2012, 32:712-721. Available from: http://mdm.sagepub.com/content/32/5/712.
25. Treasury H.M. The Green Book consultation paper. Appraisal and evaluation in central government 2002, Accessed 26th June 2009. online. Available from: http://www.hm-treasury.gov.uk/d/4(4).pdf.
26. Thompson K.M., Graham J.D. Going beyond the single number: using probabilistic risk assessment to improve risk management. Hum Ecol Risk Assess: Int J 1996, 2(4):1008-1034.
27. Fenwick E, Claxton K, Sculpher M, Briggs A. Improving the efficiency and relevance of health technology assessment: the role of iterative decision analytic modelling. CHE discussion paper. The University of York, Center for Health Economics; 2000.
28. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999, 18(June (3)):341-364.
29. Claxton K., Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996, 5(6):513-524. Available from: http://dx.doi.org/3.0.CO;2-9.
30. Phelps C.E., Mushlin A.I. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care 1991, 7(1):12-21.
31. Stinnett A.A., Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998, 18(2 Suppl.):S68-S80.
32. Palmer S., Smith P.C. Incorporating option values into the economic evaluation of health care technologies. J Health Econ 2000, 19(September (5)):755-766.
33. Johannesson M., Weinstein M.C. On the decision rules of cost-effectiveness analysis. J Health Econ 1993, 12(December (4)):459-467.
34. Fenwick E., Claxton K., Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001, 10(December (8)):779-787.
35. National Institute for Health & Clinical Excellence (NICE) Guide to the methods of technology appraisal 2008, NICE, London.
36. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5(March (3)):e74. Available from: http://dx.doi.org/10.1371/journal.pmed.0050074.
37. BNF. British National Formulary, release 57, Joint Formulary Committee. Available from: http://bnf.org/bnf/bnf/current/index.htm.
38. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006, 24(February (8)):1047-1062. Available from: PM: 16298026.
39. Loeb M., Russell M.L., Moss L., Fonseca K., Fox J., Earn D.J.D., et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. J Am Med Assoc 2010, 303(March (10)):943-950. Available from: http://dx.doi.org/10.1001/jama.2010.250.
40. Jefferson T., Rivetti D., Rivetti A., Rudin M., Pietrantonj C.D., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366(October (9492)):1165-1174. Available from: http://dx.doi.org/10.1016/S0140-6736(05)67339-4.
41. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7(October (10)):658-666. Available from: http://dx.doi.org/10.1016/S1473-3099(07)70236-0.
42. Vynnycky E., Pitman R., Siddiqui R., Gay N., Edmunds W.J. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008, 26(September (41)):5321-5330. Available from: http://dx.doi.org/10.1016/j.vaccine.2008.06.101.
43. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23(January (10)):1284-1293. Available from: http://dx.doi.org/10.1016/j.vaccine.2004.08.044.
44. Luce B.R., Zangwill K.M., Palmer C.S., Mendelman P.M., Yan L., Wolff M.C., et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics 2001, 108(August (2)):E24.
45. Salo H., Kilpi T., Sintonen H., Linna M., Peltola V., Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006 Jun, 24(23):4934-4941. Available from: http://dx.doi.org/10.1016/j.vaccine.2006.03.057.
46. Hall J.L., Katz B.Z. Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months. J Pediatr 2005, 147(December (6)):807-811. Available from: http://dx.doi.org/10.1016/j.jpeds.2005.06.031.
47. Navas E., Salleras L., Domínguez A., Ibáñez D., Prat A., Sentís J., et al. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 2007, 25(April (16)):3233-3239. Available from: http://dx.doi.org/10.1016/j.vaccine.2007.01.038.
48. Hurwitz E.S., Haber M., Chang A., Shope T., Teo S., Ginsberg M., et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. J Am Med Assoc 2000, 284(October (13)):1677-1682.
49. Principi N., Esposito S., Gasparini R., Marchisio P., Crovari P., Group F.F.S. Burden of influenza in healthy children and their households. Arch Dis Child 2004, 89(November (11)):1002-1007.
50. Centers for Disease Control & Prevention (CDC). Final state-level influenza vaccination coverage estimates for the 2010-11 season-United States, National Immunization Survey and Behavioral Risk Factor Surveillance System, August 2010 through May 2011; 2011. Available from: http://www.cdc.gov/flu/professionals/vaccination/coverage_1011estimates.htm.
51. Anderson R.M. The concept of herd immunity and the design of community-based immunization programmes. Vaccine 1992, 10(13):928-935.
52. Nokes D.J., Anderson R.M. The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiol Infect 1988, 101(August (1)):1-20.
53. Anderson R.M., May R.M. Immunisation and herd immunity. Lancet 1990, 335(March (8690)):641-645.
54. Monto A.S., Koopman J.S., Bryan E.R. The Tecumseh Study of Illness. XIV. Occurrence of respiratory viruses, 1976-1981. Am J Epidemiol 1986, 124(September (3)):359-367.
55. Vynnycky E., Edmunds W.J. Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect 2008, 136(February (2)):166-179. Available from: http://dx.doi.org/10.1017/S0950268807008369.
56. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167(April (7)):775-785. Available from: http://dx.doi.org/10.1093/aje/kwm375.
57. Cooper B.S., Pitman R.J., Edmunds W.J., Gay N.J. Delaying the international spread of pandemic influenza. PLoS Med 2006 Jun, 3(6):e212. Available from: http://dx.doi.org/10.1371/journal.pmed.0030212.
58. Office for National Statistics; 2005. Available from: http://www.statistics.gov.uk/.
59. Brisson M., Edmunds W.J., Gay N.J., Law B., Serres G.D. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000, 125(December (3)):651-669.